| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 01/04/2011 | US7862827 Combination neisserial compositions |
| 01/04/2011 | US7862819 Mammal polynucleotides; binding to monoclonal antibodies |
| 01/04/2011 | US7862816 Identifying ephrin inhibitors for use in treatment and prevention of cell proliferative and angiogenesis disorders; antitumor agents |
| 01/04/2011 | US7862815 Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP) |
| 01/04/2011 | US7862814 Method of inhibiting the proliferation of B cell cancers using TACI-immunoglobulin fusion proteins |
| 01/04/2011 | CA2573307C Use of platelet aggregation inhibitors |
| 01/04/2011 | CA2503535C Novel compositions with chitinase activity |
| 01/04/2011 | CA2490020C Improved method for the prevention or reduction of haze in beverages |
| 01/04/2011 | CA2487060C Humanized immunomodulatory monoclonal antibodies for the treatment of neoplastic disease or immunodeficiency |
| 01/04/2011 | CA2459013C Proteins having effects of controlling cell migration and cell death |
| 01/04/2011 | CA2451614C Dual resonance energy transfer nucleic acid probes |
| 01/04/2011 | CA2449782C Qtl controlling sclerotinia stem rot resistance in soybean |
| 01/04/2011 | CA2449054C Integrin targeting liposome for nucleic acid delivery |
| 01/04/2011 | CA2447335C Targeted delivery of drugs for the treatment of viral infections |
| 01/04/2011 | CA2424332C Method of detecting norwalk-like virus (gi) |
| 01/04/2011 | CA2406240C Hcv anti-core monoclonal antibodies |
| 01/04/2011 | CA2401545C Mutated cyclin g1 protein |
| 01/04/2011 | CA2392711C Method for measuring the activity of deacetylase and method of screening for inhibitors and accelerators of the enzyme |
| 01/04/2011 | CA2392075C Method for the preparation of purified hcv rna by exosome separation |
| 01/04/2011 | CA2390141C Novel compositions and processes for improved analyte detection using hybridization assays |
| 01/04/2011 | CA2389206C Activation of hcv-specific t cells |
| 01/04/2011 | CA2388301C Modified gp100 and uses thereof |
| 01/04/2011 | CA2382848C Diagnostics and therapeutics for osteoporosis |
| 01/04/2011 | CA2361181C Her-2 binding antagonists |
| 01/04/2011 | CA2354154C A.beta.-peptide screening assay |
| 01/04/2011 | CA2353379C Lipolytic enzyme variants |
| 01/04/2011 | CA2350127C Avipox vector coding an hiv antigen and a cytokine |
| 01/04/2011 | CA2340174C Compositions of cpg and saponin adjuvants and methods thereof |
| 01/04/2011 | CA2335645C Use of interferon alpha 5 in the treatment of viral liver diseases |
| 01/04/2011 | CA2326405C Novel genetically modified lactic acid bacteria having modified diacetyl reductase activities |
| 01/04/2011 | CA2324165C Recombinant major allergen of the pollen of artemisia vulgaris (mugwort) |
| 01/04/2011 | CA2319110C Hybrid seed production |
| 01/04/2011 | CA2311931C Fluorometric method for monitoring and detecting nucleic acid amplification |
| 01/04/2011 | CA2303407C Regulation of gene expression in plants |
| 01/04/2011 | CA2301920C Vaccine |
| 01/04/2011 | CA2272046C Infectious clones of rna viruses and vaccines and diagnostic assays derived thereof |
| 01/04/2011 | CA2269105C Environmental stress-tolerant plants |
| 01/04/2011 | CA2268865C Anti-p53 single-chain antibody fragments and their uses |
| 01/04/2011 | CA2248869C Allele suppression |
| 01/04/2011 | CA2190149C Dna sequences coding for enzymes capable of facilitating the synthesis of linear .alpha.-1,4 glucans in plants, fungi and microorganisms |
| 01/04/2011 | CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/04/2011 | CA2154265C Methods and diagnostic kits utilizing mammalian stress promoters to determine toxicity of a compound |
| 01/04/2011 | CA2142575C Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma |
| 01/04/2011 | CA2132103C Encoded combinatorial chemical libraries |
| 01/04/2011 | CA2101774C Test and model for alzheimer's disease |
| 01/04/2011 | CA2068654C Varicella-zoster virus antigen |
| 12/30/2010 | US20100333238 Method For Inducing Resistance To Fungal Infection In Transgenic Plants Using Plant Defense Peptides |
| 12/30/2010 | US20100333233 Cottonwood Growth eIF-5A |
| 12/30/2010 | US20100333232 transgenic plant comprising in its genome a transgene encoding a member FLOWERING LOCUS C (FLC) gene family; having early timing of its flowering; seeds; genetic engineering |
| 12/30/2010 | US20100333231 Maize Promoter P95 and Methods of Use |
| 12/30/2010 | US20100333230 Closterovirus vectors and methods |
| 12/30/2010 | US20100333229 Soybean Cultivar 2229021658 |
| 12/30/2010 | US20100333223 Carbohydrate binding plant hydrolases which alter plant cell walls |
| 12/30/2010 | US20100333222 Knockout mice for a p450 gene cluster |
| 12/30/2010 | US20100333221 Mutated hyperthermophilic phosphotriesterases and uses thereof |
| 12/30/2010 | US20100333220 Human tissue factor-producing knock-in non-human animal |
| 12/30/2010 | US20100333218 Transgenic proteins from multi-gene systems, methods, compositions, uses and the like relating thereto |
| 12/30/2010 | US20100333216 Non-human gene-disrupted animal with disrupted Adam11 gene |
| 12/30/2010 | US20100331537 Novel surface antigen |
| 12/30/2010 | US20100331536 CA125 gene and its use for diagnostic and therapeutic interventions |
| 12/30/2010 | US20100331528 Isolated Antibodies Against Biologically Active Leptin-Related Peptides |
| 12/30/2010 | US20100331395 Decoy-containing pharmaceutical compositions and method of using the same |
| 12/30/2010 | US20100331394 Methods and Compositions for the Treatment of Eye Disorders with Increased Intraocular Pressure |
| 12/30/2010 | US20100331393 Compositions and methods of sphingosine kinase inhibitors in radiation therapy of various cancers |
| 12/30/2010 | US20100331392 Antidotes to antisense compounds |
| 12/30/2010 | US20100331390 Effects of apolipoprotein b inhibition on gene expression profiles in animals |
| 12/30/2010 | US20100331253 Method for cell adhesion and wound healing |
| 12/30/2010 | US20100331251 Polypeptides homologous to vegf and bmp1 |
| 12/30/2010 | US20100331250 Anti-angiogenesis fusion proteins |
| 12/30/2010 | US20100331237 Gag binding proteins |
| 12/30/2010 | US20100331217 Substrate preparation process |
| 12/30/2010 | US20100331214 siRNA Targeting Survivin |
| 12/30/2010 | US20100331208 Cell Display Of Antibody Libraries |
| 12/30/2010 | US20100331193 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| 12/30/2010 | US20100330678 Process for the stable gene interruption in clostridia |
| 12/30/2010 | US20100330677 Improved Reprogramming of Mammalian Cells, and Cells Obtained |
| 12/30/2010 | US20100330676 Expression of surrogate light chains |
| 12/30/2010 | US20100330675 Insulating polynucleotides derived from element d4z4 and their uses in transgenesis |
| 12/30/2010 | US20100330669 Fvii or fviia variants |
| 12/30/2010 | US20100330667 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level |
| 12/30/2010 | US20100330666 Vectors and Methods for Tissue Specific Synthesis of Protein in Eggs of Transgenic Hens |
| 12/30/2010 | US20100330657 Activin receptor-like kinases, proteins having serine threonine kinase domains and their use |
| 12/30/2010 | US20100330649 Expression systems for functional membrane polypeptides |
| 12/30/2010 | US20100330647 Enzyme for the Production of Long Chain Peracid |
| 12/30/2010 | US20100330646 Thermostable catalase |
| 12/30/2010 | US20100330639 Designer Oxyphotobacteria and Greenhouse Distillation for Photobiological Ethanol Production from Carbon Dioxide and Water |
| 12/30/2010 | US20100330634 Mutants Having Capability To Produce 1, 4-Butanediol And Method For Preparing 1, 4-Butanediol Using The Same |
| 12/30/2010 | US20100330632 Cis-aconitate Decarboxylase Mutants Having Improved Enzymatic Activity |
| 12/30/2010 | US20100330631 Cis-aconitate Decarboxylase Mutants Having Improved Enzymatic Activity |
| 12/30/2010 | US20100330624 Vector for transformation using transposons, microorganisms transformed by the vector, and method for producing L-lysine using the same |
| 12/30/2010 | US20100330623 Compositions and methods for amino acid biosynthesis |
| 12/30/2010 | US20100330619 Direct multiplex characterization of genomic dna |
| 12/30/2010 | US20100330618 Methods for producing biological substances in pigment-deficient mutants of bacillus cells |
| 12/30/2010 | US20100330617 Methods of Producing a Secreted Protein |
| 12/30/2010 | US20100330616 Novel endoribonuclease |
| 12/30/2010 | US20100330614 Global transcription machinery engineering targeting the rnap alpha subunit (rpoa) |
| 12/30/2010 | US20100330591 GPCR Expressing Cell Lines and Antibodies |
| 12/30/2010 | US20100330590 Assays using chimeric t1r3 taste receptor polypeptides |
| 12/30/2010 | US20100330583 Compositions and methods for identification of PARP function, inhibitors, and activators |
| 12/30/2010 | US20100330572 Organic compounds |